Liver Cirrhosis  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT00056862: Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Completed
4
58
US
Peginterferon alfa-2a, Pegasys, Ribavirin, Copegus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hepatitis C
01/10
06/10
NCT01938781: Optimized Treatment and Regression of HBV-induced Liver Fibrosis

Completed
4
400
RoW
entecavir, entecavir dispersible tablets, Peg-IFN, Pegasys
Beijing Friendship Hospital, Peking University People's Hospital, RenJi Hospital, Peking University, Shanghai Zhongshan Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Public Health Clinical Center, Nanfang Hospital of Southern Medical University, Sir Run Run Shaw Hospital, Beijing YouAn Hospital, Peking University First Hospital, Beijing 302 Hospital, Peking Union Medical College Hospital, Beijing Ditan Hospital, Beijing Tiantan Hospital, Huashan Hospital, Tongji Hospital, Tang-Du Hospital, Fifth Hospital of Shijiazhuang City, Logistics University of Chinese People's Armed Police Forces, The First Affiliated Hospital of Shanxi Medical University, The Affiliated Hospital of Yanbian University
Liver Fibrosis
12/16
12/16

Download Options